OssDsign
OssDsign is a Swedish medical technology company focused on products used in spine surgery and orthobiology. The group operates through OssDsign AB and its subsidiaries in the U.S., the U.K. and Scotland, with sales activities conducted through OssDsign USA Inc.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueBone graft and fusion products used in spinal procedures.
Patient-specific cranial implant solutions for neurosurgical reconstruction.
Clinical evidence generation, education and market support around products.
Customers
OssDsign sells primarily to hospitals, surgeons and healthcare systems that perform spine and cranial procedures. Its products are used in clinical settings where surgeons value evidence-backed implants and bone graft materials that support complex reconstructive and fusion cases.
Buy products for surgical departments that treat spine and cranial reconstruction cases.
Use OssDsign Catalyst in fusion procedures where clinical evidence and handling matter.
Use Cranial PSI for patient-specific cranial reconstruction cases.
Support market access and product placement in selected geographies.
Strategy
OssDsign’s strategy centers on building clinical evidence around OssDsign Catalyst and using that evidence to expand adoption with surgeons and hospitals. The company is also focused on scaling its U.S. commercial platform and broadening its product range to support long-term growth and eventual operating profitability.
Published outcomes help differentiate the products in a crowded medtech market.
The U.S. is the core revenue market and the main platform for scaling adoption.
A broader offering can increase procedure coverage and customer relevance.
Geography
OssDsign is headquartered in Uppsala, Sweden, but its commercial footprint is centered in the United States. The reports show U.S. net sales as the only disclosed geographic revenue market, and the company also maintains subsidiaries in England, Scotland and Maryland to support operations and sales.
Risks
OssDsign faces typical medtech risks tied to regulation, product liability, intellectual property and clinical adoption. It also has financial exposure to foreign exchange, future financing needs and the concentration of sales in the U.S., which can amplify the impact of commercial or regulatory setbacks.
- Regulatory and licensing riskImpact: HighLikelihood: Medium
Medical devices must meet government and industry requirements before sale and use.
Exposure: Product development and commercialization
- Future financing riskImpact: HighLikelihood: Medium
Growth and product development can require external capital before cash generation.
Exposure: Corporate funding and expansion plans
- Product liability riskImpact: HighLikelihood: Low
Implantable products can create claims if outcomes or safety are challenged.
Exposure: Clinical use and post-market surveillance
- Intellectual property riskImpact: MediumLikelihood: Medium
The company depends on patents and know-how to protect its products.
Exposure: Catalyst and cranial implant portfolio
- Foreign exchange riskImpact: MediumLikelihood: Medium
Operations and sales span SEK, USD and other currencies.
Exposure: U.S. sales and group reporting
Accounting
Judgemental itemsDevelopment spending is partly recognized as intangible assets, affecting EBITDA and asset balances.
Impact: Reported operating expenses and intangible assets
Recoverable value depends on future cash flow and discount-rate assumptions.
Impact: Potential write-downs of goodwill or development assets
Parent-company sales timing can differ from external group sales because inventory is held in the U.S.
Impact: Quarterly comparability and revenue recognition timing
USD/SEK movements affect reported sales and margins in SEK.
Impact: Reported revenue, gross margin and operating result
Similar listed companies
Publicly listed companies with a comparable business focus.
Orthofix Medical Inc.
OFIX · Surgical & Medical Instruments & Apparatus
Alphatec Holdings, Inc.
ATEC · Surgical & Medical Instruments & Apparatus
Globus Medical, Inc
GMED · Surgical & Medical Instruments & Apparatus
Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures.
Bone Biologics Corp
BBLGW · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Bone Biologics Corp is a U.S.-based clinical-stage medical device company focused on bone regeneration for spinal fusion procedures.
Ascelia Pharma
ACE · Health Care
Ascelia Pharma is a Swedish pharmaceutical company headquartered in Malmö, with a US base in New Jersey.
Hansa Biopharma
HNSA · Health Care
Hansa Biopharma is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative treatments for rare immunological conditions.
Last updated: 24/09/2026